Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Laszlo Gyulai, MD

Laszlo Gyulai, MD Physician

Director, Bipolar Disorders Unit
Emeritus Associate Professor CE of Psychiatry

Languages spoken:

  • Hungarian

Dr. Gyulai is a Penn Medicine employed physician.

About Dr. Laszlo Gyulai

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Recognized in Philadelphia Magazine's May 2002 Top Docs issue

Clinical Specialties

Specialty:

  • Psychiatry

Programs & Centers:

Board Certification:

  • Psychiatry, 1991

Practice Locations and Appointments

  • Psychiatry

    Penn Behavioral Health 3535 Market Street Philadelphia, PA 19104 866-301-4PBH (4724)

    A facility of the Hospital of the University of Pennsylvania

Education and Training

Medical School: Semmelweis Oorvostudomanyi Egyetem
Residency: Mercy Fitzgerald Hospital
Residency: Hospital of the University of Pennsylvania

Memberships

Abbott Laboratories, Glaxo-Wellcome, Bristol-Meyers-Squibb, American Psychiatric Association, American Suicide Foundation, Data Monitoring Board for “Reducing the Efficacy-Effectiveness Gap in Bipolar Disorder” (P.I.: Dr. Mark S. Bauer), Department of Veterans Affairs, Washington D.C., Institutional Development Grant Program, North Carolina Biotechnology Center, Society of Nuclear Medicine, Special Programs, Office of Vocational Rehabilitation, Commonwealth of Pennsylvania,

Hospital Affiliation

Dr. Gyulai is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Gyulai, L., Bauer M., Bauer,M.S., Espana-Garcia, F, Whybrow, P.C.: Lithium challenge to the thyroid axis in rapid cycling bipolar affective disorder and healthy controls Biological Psychiatry 53 : 899-905,2003.

Gyulai L. Bowden CL. McElroy SL. Calabrese JR. Petty F. Swann AC. Chou JC. Wassef A. Risch CS. Hirschfeld RM. Nemeroff CB. Keck PE Jr. Evans DL. Wozniak PJ.: Maintenance efficacy of divalproex in the prevention of bipolar depression Neuropsychopharmacology 28 : 374-82,2003.

Gyulai, L., Bauer, M., Garcia-Espana, F., Hierholzer, J., Baumgartner, A., Whybrow, P.C.: Supressive doses of thyroxine and bone mineral density in pre- and postmenopasual women with affective disorder J. of Affective Disorders 66 : 185-191,2001.

Nemeroff, C., Evans, D., Gyulai, L., Sachs, G., Bowden, C., Young, M., Pitts, C., Oaks, R., Gergel, I.: A Double-Blind, Placebo-Controlled comparison of imipramine and paroxetine in the treatment of bipolar depression American Journal of Psychiatry 158 : 906-912,2001.

Cory Newman, Noreen Reilly-Harrington, Laszlo Gyulai, Aaron T. Beck: Cognitive Therapy of Bipolar Disorder : 2001.

Bowden, C. H., Calabrese, J., McElroy, S., Gyulai, L., Wassef, A., Petty, F., Pope, HG., Chou C-Y., Keck, P., Rhodes, L., Swann, A., Hirschfeld, RM., Wozniak, P.: Randomized, Placebo-Controlled Trial of Divalproex Versus Lithium in Maintenance Therapy of Bipolar Disorder Arch. Gen. Psychiatry 57 : 481-489,2000.

Sachs GS. Printz DJ. Kahn DA. Carpenter D. Docherty JP.: The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 Postgraduate Medicine : 1-104,2000.

Bauer, M, Berghoefer, A, Baumgartner, A, Gyulai, L, Whybrow, P.C.: T4 Enhancement in Bipolar and Unipolar Illness Neuropsychopharmacology 23 : S68,2000.

Hahn, C., Pawlyk A.C., Whybrow, P.C., Gyulai, L.,Tejani-Butt, S.M.: Lithium Administration Affects Gene Expression of Thyroid Hormone Receptors in Rat Brain Life Sciences 64 (20): 1793-1802,1999.

Rapaport, M.H., Gyulai,L. Whybrow, P.C.: Immune Parameters in Rapid Cycling Bipolar patients Before and After Lithium Treatment J. Psychiatry Research 33 : 335-340,1999.

Academic Contact Info

HUP
3400 SPRUCE ST.
4283

Philadelphia, PA 19104
Phone: (215) 898-4387
Patient appointments: 866-301-4PBH (4724)